PhytoNova

PhytoNova is a South African biotechnology company focused on the research, development, and commercialization of medicines derived from indigenous African plants. The company is most notable for its pioneering work on Sutherlandia frutescens (also known as the Cancer Bush), which has been traditionally used to treat a variety of ailments. PhytoNova has conducted clinical research to evaluate the safety and efficacy of Sutherlandia extracts in patients with HIV/AIDS and other chronic conditions. By bridging traditional ethnobotanical knowledge with modern clinical science, the company aims to provide accessible and scientifically validated therapeutic options. Their product portfolio includes standardized tablets and gels intended for immune support and metabolic health.